Conference Coverage

VIDEO: Smell test reflects brain pathologies, risk of Alzheimer’s progression


 

AT AAIC 2016

Dr. Richard Caselli, professor of neurology at the Mayo Clinic, Scottsdale, Ariz., commented on the limited clinical utility of the UPSIT in a video interview.

Neither Dr. Lee nor Dr. Kreisl had any financial declarations.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Pages

Recommended Reading

Medicare annual wellness visit remains underused
MDedge Family Medicine
VIDEO: Proposed Alzheimer’s funding boost could mean wider research scope
MDedge Family Medicine
VIDEO: Alzheimer’s anti-tau drug fails, but shows hint of effect when taken alone
MDedge Family Medicine
Alzheimer’s anti-tau drug fails phase III, but posts some benefit in monotherapy subanalysis
MDedge Family Medicine
Postop delirium linked to greater long-term cognitive decline
MDedge Family Medicine
Driving skills already affected with mild cognitive impairment
MDedge Family Medicine
Checklist captures new predementia diagnosis of mild behavioral impairment
MDedge Family Medicine
Early Alzheimer’s treatment decreases both costs and mortality
MDedge Family Medicine
Retinal nerve fiber layer thinning predicts cognitive decline
MDedge Family Medicine
Studies suggest moving SNAP outside of Alzheimer’s framework
MDedge Family Medicine